Skip to main content
Account
0
Items
Products
Pharmacology
GPCRs / 7-TM Receptors
Enzyme-Linked Receptors
Enzymes
Ion Channels
Nuclear Receptors
Transporters
Other Pharmacology
All Targets
Cell Biology
Angiogenesis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Regulated Cell Death
Signal Transduction
Stem Cells
Product Type
All Products
Small Molecules
Peptides
Chemogenetics
Controlled Substances
Compound Libraries
Fluorescence Imaging
GMP & Ancillary Material Grade Small Molecules
Optopharmacology
PROTACs & Targeted Protein Degradation
Reagents
Stapled Peptides
Toxins
Research Area
Cancer
Cardiovascular System
Cell and Gene Therapy
COVID-19 Research
Endocrinology
Immunology
Infectious Disease
Neuroscience
Pain & Inflammation
Respiratory System
New Products
Support
Customer Support
Technical Support
Contact Us
Distributors
Leave Feedback
Scholarship Program
Submit a Review
Promotions
Bulk Quantity Discounts
GMP Compound Register Interest
Screening Inquiry
Resources
Signaling Pathways
Peptide Nomenclature Guide
Pharmacological Glossary
Useful Abbreviations
Dilution Calculator
Molarity Calculator
Reconstitution Calculator
Protocols
Tocris Blog
Webinars & Videos
Spectra Viewer
Services
Custom Synthesis
Chemical Analysis
Chemical Sourcing
Facilities
Expertise
Why Choose Tocris?
Request Quote
Custom Compound Library Service
Custom Degrader Services
PROTAC® Panel Builder
Literature
Life Science Posters
Scientific Meeting Posters
Product Guides & Listings
Research Bulletins
Scientific Reviews
Sign Up for E-Alerts
Request Literature
About Tocris
Your Supplier of Choice
Tocris History
Tocris in the News
Events & Conferences
Licensing
Our Ethos
Environment
Careers
Contact Us
Filter Results
Products (10)
"
神话棋牌官网版『完美体育官网:ww81.cc』-ikaswsaic
" has 10 results in Products.
Results per Page:
5
10
20
30
PhiKan 083
Cat. No. 4326/10
1 Citation
Description:
p53 stabilizing agent
Purity:
≥99% (HPLC)
Pricing & Availability
Qty
Baicalein
Cat. No. 1761/50
6 Citations
Description:
5- and 12-Lipoxygenase inhibitor
Purity:
≥98% (HPLC)
Pricing & Availability
Qty
Montelukast sodium
Cat. No. 5904/10
1 Citation
Description:
CysLT
1
and GPR17 antagonist
Purity:
≥99% (HPLC)
Pricing & Availability
Qty
CM 11
Cat. No. 6416/5
Description:
Homo-PROTAC
®
for self-degradation of pVHL30
Purity:
≥98% (HPLC)
Pricing & Availability
Qty
CRBN PROTAC
®
14a
Cat. No. 7219/5
Description:
Cereblon Degrader (PROTAC
®
)
Purity:
≥98% (HPLC)
Pricing & Availability
Qty
VH 032 amide-PEG4-acid
New
Cat. No. 7215/25
Description:
VHL ligand with PEG linker and terminal acid for onward chemistry
Purity:
≥95% (HPLC)
Pricing & Availability
Qty
Pomalidomide 4'-PEG6-azide
Cat. No. 7438/25
Description:
Cereblon ligand with PEG linker and terminal azide for onward chemistry
Purity:
≥95% (HPLC)
Pricing & Availability
Qty
Okadaic acid
Cat. No. 1136/25U
28 Citations
2 Reviews
Description:
Protein phosphatase 1 and 2A inhibitor
Pricing & Availability
Qty
AICAR
Cat. No. 2840/50
20 Citations
1 Review
Description:
AMPK activator
Purity:
≥99% (HPLC)
Pricing & Availability
Qty
(
E
)-Capsaicin
Cat. No. 0462/100
38 Citations
Description:
TRPV agonist
Purity:
≥98% (HPLC)
Pricing & Availability
Qty
Page
of 1
"
神话棋牌官网版『完美体育官网:ww81.cc』-ikaswsaic
" has results in Targets.
"
神话棋牌官网版『完美体育官网:ww81.cc』-ikaswsaic
" has results in Resources.
Back to Search Results
Apply
Filters
Clear All
Citations
1 Or More (6)
10 Or More (3)
Reviews
5 (1)
4 & Up (2)
Categories
Active Degraders
(2)
Ubiquitin E3 Ligases
(2)
AMPK
(1)
Cell Cycle Inhibitors
(1)
Cereblon Ligands-Linkers
(1)
Enzyme Substates Activators
(1)
Ferroptosis
(1)
Leukotriene Receptors
(1)
Lipoxygenase
(1)
Mesenchymal Stem Cells
(1)
Osteogenic Stem Cells
(1)
Ser/Thr Phosphatases
(1)
TRPV Channels
(1)
VHL Ligands Plus Linkers
(1)
P53
(1)
Product Action
Building Block
(2)
Degrader
(2)
Inhibitor
(2)
Activator
(1)
Agonist
(1)
Antagonist
(1)
Other
(1)
Product Type
Small Molecule
(6)
Kit
(4)
Need help?
×
How can we help you?
Close
Start Chat
© Copyright 2022 Tocris Bioscience. All Rights Reserved.
Privacy and Cookie Policy
|
Site Map